Delivery Order SPE2DR25D1053-SPE2DR26FX902
Award Date 4/8/26
Potential Completion Date 4/29/26
Potential Value $9.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,649.10 delivery order to Amerisourcebergen Drug Corp on April 8, 2026, for HYPERRAB 300 unit/mL vial 5mL pharmaceutical supply. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April...
- The Defense Logistics Agency issued a $9,894.60 delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for HYPERRAB 300 unit/mL vial 5mL pharmaceutical product, with ultimate completion on April 3, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency issued a $8,245.50 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for HYPERRAB 300 unit/ml vial 5ml pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 17, 2026, for HYPERRAB 300 unit/mL vial 5mL with a ceiling value of $8,245.50. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DX, a $999,999,999 global pharmaceutical supply vehicle through December 2026 supporting military healthcare programs. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with an ultimate...
- The Defense Logistics Agency issued a $2,993.55 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for HYPERRAB 300 Unit/ML Vial 3ML pharmaceutical product. The order was placed under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999.00 through December 2026, which provides global pharmaceutical and medical supply support to military healthcare programs. Place of performance is Conshohocken, PA. Ultimate completion date is April 27,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5mL. This is a firm fixed-price delivery order under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 17, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5 mL pharmaceutical supply. Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion by March 10, 2026. Pricing is firm fixed price. The delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026,...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for Hyperrab 300 unit/mL vials (5 mL), with a ceiling value of $65,964.00. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of April 10, 2026. No set-aside was used.
- The Defense Logistics Agency issued a $32,982 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 6,...
- <p>The Defense Logistics Agency issued a $15,792 delivery order to AmerisourceBergen Drug Corp on April 8, 2026, for supply of HYPERRAB 300 unit/mL vaccine under its parent Indefinite Delivery Contract with DLA Troop Support Medical.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of April 29, 2026. No set-aside was used.</p>